Health Condition 1: G438- Other migraine
Conditions
Interventions
Intervention1: Tablet Propranolol 40mg: Tablet Propranolol was started with 40mg/day for first 5 days and increased to
40mg twice a day respectively for 2months
Control Intervention1: Tablet Flunari
Sponsors
Dr. Rajendra Prasad Government Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients willing to give consent. 2) Male and female outpatients between 18-65 years of age with documented history of migraine (with or without aura) acc. to HIS criteria. 3) Duration of at least 3 months. 4) Frequency of two or more migraine headache per month. 5) Currently not on any prophylactic medication in the last 1 month. 6) Patientsâ?? ability to fill a reliable headache diary successfully.
Exclusion criteria
Exclusion criteria: 1) Patients refusing to give consent. 2) 65 of age with non-migrainous headache. 3) Pregnant and Lactating women. 23 | P a g e 4) Patients with h/o asthma, diabetes, renal, cardiovascular, liver, neoplastic disease, neurological and mental disorders are excluded. 5) Active alcohol users. 6) Patients allergic or with known contraindications to any of study drugs. 7) Patients who have already taken either of the above-mentioned migraine prophylactic drugs. 8) Previous unresponsiveness to more than two antimigraine prophylactic drugs. 9) NCCT Head suggesting of any other disease except migraine i.e., abnormal fundus etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in frequency intensity and severity of migraine attacksTimepoint: at baseline at 4 weeks and at 8 weeks from date of enrollment | — |
Secondary
| Measure | Time frame |
|---|---|
| to evaluate safety profile to both drugsTimepoint: at baseline at 4 weeks and at 8 weeks from date of enrollment | — |
Countries
India
Contacts
Public ContactDrAtal Sood
DR. Rajendra Prasad Government Medical College Kangra at Tanda
Outcome results
None listed